Sleep-Disordered Breathing and Nocturnal Hypoxia in Cancer Patients: A Stomatological and Airway Assessment Framework Authors: Carlos Mas Bermejo, Carlos Mas Gómez, Luis-Alberto Bravo-González Published: 2026 ABSTRACT AbstractBackgroundPatients with cancer frequently experience sleep-related symptoms and physiological disturbances that may be associated with sleep-disordered breathing (SDB) and nocturnal hypoxia. Although these conditions have attracted increasing attention in oncology, the potential contribution of craniofacial restriction and upper airway dysfunction remains insufficiently recognized in routine clinical practice.ObjectiveTo propose a stomatological and upper airway assessment framework for the identification of anatomical factors that may contribute to sleep-disordered breathing and nocturnal hypoxia in adults with cancer.MethodsThis narrative review integrates current evidence on sleep-disordered breathing, nocturnal hypoxia, craniofacial development, and upper airway dysfunction. The proposed framework was developed from recurrent clinical observations in adults with cancer together with a narrative synthesis of the available literature, with emphasis on anatomical findings identifiable during routine stomatological examination.Main FindingsCurrent evidence indicates that anatomical features such as maxillary constriction, nasal airway narrowing, altered craniofacial development, and ankyloglossia may contribute to upper airway dysfunction and nocturnal hypoxia. Despite increasing recognition of the systemic consequences of nocturnal hypoxia, these upstream anatomical factors are rarely incorporated into routine oncological assessment. Based on the available evidence, a practical clinical framework is proposed to facilitate early identification of patients who may benefit from further respiratory evaluation.ConclusionIntegrating stomatological and upper airway assessment into the multidisciplinary evaluation of adults with cancer may improve recognition of previously unrecognized sleep-disordered breathing and nocturnal hypoxia. This framework provides a clinically applicable approach for identifying potentially modifiable anatomical contributors to respiratory dysfunction and may support future research evaluating their relevance in supportive cancer care.Keywords: sleep-disordered breathing, nocturnal hypoxia, obstructive sleep apnea, craniofacial abnormalities, upper airway dysfunction, cancer, hypoxic burden, stomatological assessment Introduction Sleep-disordered breathing (SDB) is a highly prevalent and frequently underdiagnosed condition characterized by recurrent disturbances in airflow and ventilation during sleep. Although traditionally classified according to respiratory event frequency, increasing evidence suggests that its systemic consequences are influenced not only by the apnea–hypopnea index (AHI), but also by nocturnal hypoxia, sleep fragmentation, autonomic activation, and impaired physiological recovery. Intermittent nocturnal hypoxia has been associated with oxidative stress, systemic inflammation, endothelial dysfunction, autonomic dysregulation, metabolic impairment, and altered immune responses. These biological mechanisms have been extensively reviewed elsewhere and are mentioned here solely to provide the physiological rationale underlying the proposed clinical framework. Importantly, many patients with sleep-disordered breathing (SDB) exhibit craniofacial and upper airway structural characteristics that may contribute to impaired nocturnal airflow and oxygenation. Anatomical features such as maxillary constriction, narrow nasal fossae, altered craniofacial development, and ankyloglossia may increase upper airway resistance, promote chronic airflow limitation, and contribute to recurrent sleep-related hypoxic stress. Based on our clinical experience, craniofacial restriction and upper airway anatomical alterations appear to be substantially underrecognized in routine oncological care. In a previous narrative review, our group proposed that restoration of physiological normoxia may represent a promising adjunctive strategy in oncology by mitigating the biological consequences of chronic intermittent hypoxia and improving the host environment in which cancer develops and is treated.1 Across different tumor types, many patients report poor sleep quality, morning fatigue, headaches, nasal obstruction, and symptoms suggestive of previously unrecognized sleep-disordered breathing. Nevertheless, structured stomatological and upper airway assessment is rarely incorporated into routine oncological evaluation. Available evidence indicates a high prevalence of sleep-related disturbances among patients with cancer. A systematic review and meta-analysis including 46,279 patients reported an overall prevalence of sleep disturbance of 60.7%, increasing to 70.8% in those with advanced disease. In patients with newly diagnosed lung cancer, home sleep testing identified obstructive sleep apnea in 80% of those evaluated, including moderate-to-severe disease in 50%, while clinically relevant nocturnal hypoxemia was also frequently observed. However, these prevalence estimates vary considerably according to tumor type, disease stage, treatment status, patient characteristics, and diagnostic methodology. Therefore, these findings should not be generalized across all oncology populations.2,3 The molecular mechanisms linking intermittent hypoxia to cancer biology have been extensively reviewed elsewhere. Therefore, the present article focuses instead on the clinical identification of upstream craniofacial and upper airway anatomical factors that may contribute to sleep-disordered breathing and chronic nocturnal hypoxia in adults with cancer. In this context, there is a need for a more integrative clinical approach capable of identifying the anatomical and functional determinants of nocturnal hypoxia in patients with cancer. While our previous work focused on the biological rationale and potential therapeutic relevance of restoring physiological normoxia in oncology,1 the present article addresses a complementary objective by proposing a structured stomatological and upper airway assessment framework for the early identification of patients at risk of sleep-disordered breathing and chronic nocturnal hypoxia. This translational framework links craniofacial restriction, sleep-disordered breathing, and chronic nocturnal hypoxia, while providing a practical clinical protocol to improve recognition, risk stratification, and multidisciplinary evaluation of frequently underrecognized sleep-related physiological disturbances in oncology patients. This article represents a narrative review and a conceptual clinical framework. It is not intended to be a systematic review but rather a translational synthesis of published evidence designed to support the clinical identification of anatomical and functional factors that may contribute to sleep-disordered breathing and chronic nocturnal hypoxia in adults with cancer. Stepwise Diagnostic Framework for Sleep-Disordered Breathing in Oncology Patients The identification of sleep-disordered breathing (SDB) in oncology patients requires an integrative diagnostic approach combining symptom recognition, stomatological examination, upper airway assessment, and objective sleep evaluation. Because nocturnal hypoxia may remain underrecognized despite relatively modest event-based indices, diagnostic assessment should extend beyond conventional apnea–hypopnea metrics and incorporate anatomical and functional factors capable of impairing nocturnal airflow and oxygenation. This stepwise framework aims to facilitate early detection of potentially underdiagnosed sleep-related physiological disturbances while supporting individualized therapeutic strategies directed at improving nocturnal ventilation and oxygen stability. It is intended to complement, rather than replace, established sleep medicine guidelines and should be integrated with standard diagnostic procedures and objective sleep testing. The proposed diagnostic and therapeutic pathway is summarized in Figure 1. Proposed phenotype- and severity-based clinical pathway for the assessment and management of sleep-disordered breathing in adults with cancer, integrating stomatological examination, upper airway assessment, objective sleep evaluation, hypoxic burden, and restoration of physiological nocturnal normoxia. Step 1: Symptom Detection and Clinical Screening The clinical evaluation begins with a systematic assessment of sleep-related symptoms and clinical suspicion of SDB. In pediatric patients, the Pediatric Sleep Questionnaire (PSQ) may help identify symptoms suggestive of upper airway dysfunction and sleep-related breathing disturbances.4 In adults, instruments such as the Epworth Sleepiness Scale, STOP-BANG questionnaire, and Pittsburgh Sleep Quality Index are commonly used to evaluate excessive daytime sleepiness, sleep quality, and the risk of obstructive sleep apnea.4–7 Common symptoms include non-restorative sleep, morning fatigue, headaches, nasal obstruction, snoring, fragmented sleep, cognitive impairment, and daytime somnolence. However, symptom severity does not always correlate with the physiological burden of nocturnal hypoxia. Step 2: Stomatological and Craniofacial Examination Stomatological and craniofacial evaluation represents a central component of the proposed diagnostic framework, particularly in oncology patients with symptoms suggestive of sleep-disordered breathing or chronic nocturnal hypoxia. Craniofacial morphology and upper airway anatomy may play an important role in determining nocturnal airflow, upper airway resistance, and ventilation during sleep. Structural features such as maxillary constriction, narrow nasal fossae, altered craniofacial development, and ankyloglossia may contribute to airflow limitation and increase susceptibility to recurrent sleep-related hypoxic stress. Clinical examination should include evaluation of maxillary development, palatal morphology, nasal airway patency, mandibular position, tongue posture, dental occlusion, and orofacial soft tissues. Particular attention should be directed toward anatomical features commonly associated with upper airway narrowing, including maxillary constriction, a high-arched palate, narrow nasal fossae, retrognathia, altered craniofacial growth patterns, and ankyloglossia. These anatomical characteristics may reduce upper airway stability and impair nasal breathing, thereby promoting chronic mouth breathing, increased inspiratory resistance, sleep fragmentation, and recurrent intermittent nocturnal hypoxia. Importantly, many of these features may remain unrecognized during routine clinical assessment despite their potential physiological relevance and possible contribution to sleep-disordered breathing. In our clinical experience, craniofacial restriction and upper airway anatomical abnormalities are frequently observed in adults with cancer across different tumor types. However, these observations should be regarded as hypothesis-generating and require confirmation through well-designed prospective clinical studies. Identification of these anatomical features may therefore help recognize patients at increased risk of previously undiagnosed sleep-disordered breathing and chronic nocturnal hypoxia. When clinically indicated, complementary imaging studies, nasal airway evaluation, orthodontic assessment, and functional upper airway analysis may provide additional characterization of anatomical restriction and ventilatory impairment. This integrative stomatological approach aims to identify potentially modifiable anatomical contributors to sleep-disordered breathing and chronic nocturnal hypoxia, thereby facilitating a more comprehensive clinical evaluation and appropriate multidisciplinary referral when indicated. Step 3a: Three-Dimensional Airway Assessment When clinically indicated, cone-beam computed tomography (CBCT) may be used to identify anatomical sites of upper airway narrowing and to characterize structural factors that may contribute to nocturnal airflow limitation. CBCT provides three-dimensional evaluation of the nasal cavity, nasopharyngeal, oropharyngeal, and hypopharyngeal airway compartments, facilitating identification of anatomical narrowing and characterization of craniofacial phenotypes that may be associated with impaired nocturnal ventilation. These findings complement the clinical and stomatological examination and may support individualized therapeutic planning within a multidisciplinary framework involving sleep medicine, otorhinolaryngology, and dental or orthodontic specialists. A representative CBCT-based three-dimensional assessment of the upper airway, including sagittal, frontal, axial, and volumetric reconstruction views, is shown in Figure 2. CBCT-based three-dimensional assessment of upper airway anatomy. (A) Sagittal view; (B) frontal view; (C) axial view; and (D) three-dimensional reconstruction of the nasopharyngeal, oropharyngeal, and hypopharyngeal airway compartments. Step 3b: Objective Sleep Study and Severity Stratification Objective assessment of sleep-disordered breathing is performed using respiratory polygraphy or polysomnography to confirm the diagnosis and characterize its physiological severity. Beyond conventional event-based metrics such as the apnea–hypopnea index (AHI), sleep studies should incorporate evaluation of oxygen desaturation patterns, cumulative hypoxic burden, and time spent below physiological oxygen saturation thresholds.8 These parameters provide a more comprehensive assessment of the physiological consequences of nocturnal airflow limitation and may improve identification of clinically relevant sleep-related hypoxic stress, particularly in patients with anatomical upper airway narrowing. Figure 3. A representative type III home respiratory polygraphy recording is shown in Figure 3. The original recording is displayed in Spanish. Relevant labels include “Flujo” (airflow), “Esfuerzo” (respiratory effort), and “SpO₂” (oxygen saturation). A representative type III home respiratory polygraphy recording. (A) Summary report showing respiratory event indices and nocturnal oxygenation parameters. (B) Graphical recording showing respiratory events and physiological signals throughout the recording period, including oxygen saturation. The recording was used in the assessment of sleep-disordered breathing and nocturnal hypoxia. Following diagnostic characterization, therapeutic decisions should be guided by the degree of hypoxic burden, the underlying anatomical and functional phenotype, and the overall severity of sleep-disordered breathing, with the primary objective of restoring stable physiological nocturnal oxygenation. Step 4: Individualized Therapeutic Approach Therapeutic management should be individualized according to the patient’s anatomical findings, physiological severity, degree of hypoxic burden, and overall clinical profile. In patients with mild sleep-disordered breathing or predominant anatomical restriction, management may include optimization of nasal breathing, respiratory physiotherapy, positional therapy, oral appliance therapy, and interventions aimed at improving upper airway patency.9–11 Patients with moderate-to-severe sleep-disordered breathing or substantial nocturnal hypoxia may require continuous positive airway pressure (CPAP) as first-line therapy. In selected patients with significant structural upper airway compromise, otolaryngologic, orthodontic, or maxillofacial interventions may also be considered as part of a multidisciplinary treatment strategy. The primary therapeutic objective is to improve nocturnal ventilation, physiological oxygenation, sleep quality, and overall physiological recovery. Treatment selection should be guided not only by the conventional severity of sleep-disordered breathing, but also by the degree of hypoxic burden and the underlying anatomical and functional phenotype. The primary therapeutic objective is the restoration of stable physiological nocturnal normoxia. In patients with mild-to-moderate sleep-disordered breathing and a lower hypoxic burden, initial management may include optimization of nasal breathing, external nasal dilators, respiratory physiotherapy, positional therapy, and mandibular advancement devices, all of which may improve upper airway patency and ventilatory efficiency.9–11 In patients with moderate-to-severe sleep-disordered breathing or a substantial hypoxic burden, continuous positive airway pressure (CPAP) should be considered the first-line treatment. CPAP effectively stabilizes the upper airway and reduces nocturnal hypoxia. In selected patients, adjunctive respiratory or oropharyngeal exercises may also be considered according to the underlying functional phenotype.12–14 Patients with suspected structural upper-airway or nasal obstruction should undergo otorhinolaryngologic evaluation to assess anatomical contributors to airflow limitation and determine whether medical or surgical interventions aimed at improving upper-airway patency are indicated. Surgical or interventional procedures may be particularly relevant in selected patients with identifiable anatomical obstruction or an inadequate response to non-invasive therapies.13,14 Importantly, treatment strategies should be individualized and periodically adjusted according to objective measures of oxygenation, with the aim of minimizing hypoxic burden and restoring sustained physiological nocturnal normoxia. Step 5: Monitoring Treatment Response and Confirmation of Nocturnal Normoxia Treatment efficacy should be evaluated through longitudinal assessment of clinical symptoms, sleep quality, hypoxic burden, and nocturnal oxygenation. Wearable nocturnal oximetry and follow-up respiratory polygraphy or polysomnography may help identify persistent oxygen desaturation, residual sleep-disordered breathing, or incomplete restoration of physiological nocturnal normoxia under real-life conditions. This dynamic reassessment supports individualized adjustment of therapeutic strategies, facilitates objective monitoring of treatment response, and promotes sustained improvement in nocturnal ventilation, oxygenation, and sleep-related physiological recovery. Physiological Determinants of Nocturnal Oxygenation Stable nocturnal ventilation depends on the coordinated interaction between upper airway patency, neuromuscular tone, respiratory control, and sleep architecture. During sleep, particularly during rapid eye movement (REM) sleep, the physiological reduction in upper airway muscle tone increases susceptibility to airflow limitation and oxygen desaturation.20–22 Upper airway anatomy plays a central role in maintaining stable nocturnal breathing. Nasal resistance, nasal valve collapse, maxillary constriction, oropharyngeal crowding, tongue posture, and craniofacial morphology may significantly impair airflow and increase upper airway resistance during sleep. These anatomical characteristics may promote mouth breathing, ventilatory instability, sleep fragmentation, and recurrent intermittent nocturnal hypoxia, thereby providing the physiological rationale for a phenotype-oriented clinical assessment.20–22 Breathing stability during sleep is also influenced by ventilatory control mechanisms, including the physiological responses to hypoxia and hypercapnia. In susceptible individuals, even partial upper airway obstruction may produce clinically relevant oxygen desaturation despite relatively modest event-based indices, highlighting the limitations of relying exclusively on the apnea–hypopnea index (AHI).21,22 Importantly, nocturnal oxygenation should be regarded as a dynamic physiological continuum influenced by upper airway anatomy, body position, sleep stage distribution, ventilatory control, and respiratory stability. This perspective supports an integrative clinical approach aimed at identifying anatomical and functional contributors to chronic nocturnal hypoxia and impaired physiological recovery during sleep.23,24 Sleep-Disordered Breathing as the Primary Cause of Nocturnal Hypoxia Sleep-disordered breathing (SDB) represents one of the most prevalent causes of chronic intermittent nocturnal hypoxia in both adult and pediatric populations. Obstructive sleep apnea is characterized by recurrent upper airway collapse during sleep, leading to airflow limitation, oxygen desaturation, sleep fragmentation, and sympathetic activation. Together, these disturbances generate sustained physiological stress extending well beyond respiratory dysfunction alone.20–22 Importantly, clinically relevant nocturnal hypoxia is not limited to severe obstructive sleep apnea. Partial upper airway obstruction, impaired nasal breathing, upper airway resistance syndrome, and inspiratory flow limitation without overt apneic events may also produce clinically significant physiological consequences despite relatively modest apnea–hypopnea index (AHI) values.20–22 Upper airway anatomy plays a central role in this process. Craniofacial restriction, maxillary constriction, narrow nasal fossae, altered tongue posture, and other anatomical abnormalities may impair nocturnal airflow and contribute to chronic intermittent sleep-related hypoxia. Many of these anatomical contributors remain underrecognized during routine clinical evaluation. Increasing evidence suggests that cumulative hypoxic burden may better reflect the biological impact of sleep-disordered breathing than respiratory event frequency alone. The molecular and physiological consequences of intermittent hypoxia have been extensively reviewed elsewhere and are referred to here only as the biological background supporting the proposed clinical framework.23–26 Collectively, these observations support a broader physiological perspective in which sleep-disordered breathing should be understood not only as a respiratory disorder, but also as a chronic source of systemic hypoxic stress with potential implications for long-term health outcomes, including cancer susceptibility. Non-Invasive Strategies to Improve Nocturnal Ventilation and Oxygen Stability Non-invasive interventions constitute the foundation of therapeutic management for many patients with sleep-disordered breathing. These approaches aim to improve nocturnal airflow, upper airway stability, ventilation, and oxygenation while minimizing treatment-related morbidity. Nasal Airflow Optimization External and internal nasal dilators may reduce nasal resistance and improve inspiratory airflow, particularly in individuals with nasal valve collapse, narrow nasal fossae, or increased upper airway resistance.12,15 Optimization of nasal breathing plays an important physiological role in sleep-related ventilation. Improved nasal airflow may reduce mouth breathing, enhance upper airway stability, improve sleep quality, and facilitate tolerance and adherence to complementary therapies such as continuous positive airway pressure (CPAP) or oral appliance therapy. In selected patients, correction of nasal airflow limitation may contribute to improved nocturnal oxygenation and reduction of sleep-related respiratory disturbances.12,15 An example of an internal nasal dilator designed to reduce nasal valve collapse and improve inspiratory airflow during sleep is shown in Figure 4. Internal nasal dilator (Best Breathe; Best Breathe Company, S.L.U., Onil, Alicante, Spain) designed to reduce nasal valve collapse and improve inspiratory airflow during sleep. (A) Nasal passages before placement of the internal nasal dilator. (B) Nasal passages with the internal nasal dilator in place, showing mechanical dilation of the nostrils. Continuous Positive Airway Pressure (CPAP) Continuous positive airway pressure (CPAP) remains the standard first-line non-invasive treatment for patients with moderate-to-severe sleep-disordered breathing. By stabilizing the upper airway during sleep, CPAP reduces airflow limitation, oxygen desaturation, and sleep fragmentation, thereby improving nocturnal ventilation and physiological oxygenation.24,27 A representative CPAP device is shown in Figure 5. Continuous positive airway pressure device used to provide pneumatic stabilization of the upper airway and improve nocturnal ventilation and oxygenation. Treatment efficacy and patient tolerance may be significantly influenced by nasal airflow conditions, particularly in individuals with nasal obstruction, increased nasal resistance, or predominant mouth breathing. For this reason, careful evaluation of the upper airway and nasal cavity should precede CPAP initiation whenever clinically appropriate. When clinically indicated, otorhinolaryngologic management aimed at improving nasal patency—including medical treatment or minimally invasive procedures such as radiofrequency or laser techniques—may enhance CPAP tolerance, facilitate treatment adherence, and improve overall therapeutic effectiveness. Despite its well-established effectiveness, long-term adherence to CPAP remains a major clinical challenge. In selected patients, particularly those with mild-to-moderate sleep-disordered breathing or poor treatment tolerance, alternative non-invasive therapeutic approaches may represent appropriate management options.27 Respiratory Physiotherapy and Breathing Retraining Respiratory physiotherapy and breathing retraining represent complementary non-invasive strategies aimed at improving ventilatory function, nasal breathing, and upper airway stability. These approaches may include diaphragmatic breathing exercises, respiratory muscle training, breathing pattern correction, and orofacial myofunctional therapy. Interventions focused on restoring nasal breathing and optimizing tongue posture may improve upper airway neuromuscular control and reduce the tendency toward posterior tongue displacement during sleep. Promotion of nasal breathing may also enhance endogenous nitric oxide delivery from the nasal cavity, contributing to pulmonary vasodilation and improved ventilation–perfusion matching, with the potential to support more efficient oxygen exchange. By addressing both functional and anatomical contributors to airflow limitation, respiratory physiotherapy may help improve nocturnal ventilation, reduce hypoxic burden, and enhance the effectiveness of other airway-directed therapies within a multimodal treatment strategy.9,28 Additional conservative measures, including positional therapy, sleep hygiene optimization, and weight management when appropriate, may further contribute to improved nocturnal breathing, sleep quality, and physiological recovery in selected patients. Oral and Upper Airway Interventions Oral and upper airway–directed interventions play an important role in the management of sleep-disordered breathing, particularly in patients with mild-to-moderate disease or poor tolerance to continuous positive airway pressure (CPAP). These approaches aim to improve upper airway patency, reduce airflow limitation, and enhance nocturnal breathing stability through both mechanical and functional mechanisms. Mandibular advancement devices (MADs) represent the principal oral appliance therapy for sleep-disordered breathing. By advancing the mandible and stabilizing tongue posture, MADs increase upper airway caliber and reduce pharyngeal collapsibility during sleep. In appropriately selected patients, these devices may improve nocturnal oxygenation, reduce sleep-related respiratory disturbances, and improve sleep quality, particularly in patients with mild-to-moderate obstructive sleep apnea.16,17 Beyond oral appliance therapy, selected patients may benefit from orthodontic, maxillofacial, or upper airway interventions aimed at correcting underlying anatomical restriction. Maxillary expansion, optimization of nasal airflow, and improvement of craniofacial airway dimensions may contribute to enhanced nocturnal ventilation, improved oxygenation, and long-term upper airway stability. These interventions are particularly relevant within a phenotype-oriented clinical framework in which craniofacial morphology, upper airway anatomy, and functional respiratory characteristics are integrated into individualized therapeutic planning. A representative mandibular advancement device used to increase upper airway caliber and reduce pharyngeal collapsibility is shown in Figure 6. Mandibular advancement device designed to advance the mandible, increase upper airway caliber, and reduce pharyngeal collapsibility in selected patients with sleep-disordered breathing. Otorhinolaryngologic Approaches to Airway Optimization Otorhinolaryngologic evaluation represents a key component of airway-centered management in sleep-disordered breathing. Structural and functional abnormalities such as septal deviation, turbinate hypertrophy, nasal valve collapse, adenotonsillar hypertrophy, pharyngeal narrowing, and tongue-related functional restrictions may significantly contribute to airflow limitation and impaired nocturnal ventilation. The otorhinolaryngologic approach focuses on identifying anatomical sites of upper airway narrowing and determining whether targeted medical or surgical interventions may improve airway patency. Procedures including septoplasty, turbinate reduction, nasal valve reconstruction, soft palate surgery, tongue base reduction, and adenotonsillectomy in appropriately selected pediatric patients may improve airflow dynamics and reduce upper airway collapsibility.13,14 Because sleep-disordered breathing is a multifactorial condition, otorhinolaryngologic interventions are most effective when integrated into a multidisciplinary therapeutic strategy. Collaboration among sleep physicians, otorhinolaryngologists, dental sleep medicine specialists, respiratory physiotherapists, orthodontists, and maxillofacial surgeons facilitates individualized management addressing both anatomical and functional contributors to sleep-related respiratory dysfunction. Within this framework, surgical and upper airway interventions should be considered components of a coordinated physiological strategy rather than isolated procedures, with the shared objective of improving nocturnal ventilation, physiological oxygenation, sleep quality, and overall physiological recovery. Multimodal and Personalized Management of Sleep-Disordered Breathing The multifactorial nature of sleep-disordered breathing requires a personalized and multimodal therapeutic approach. In many patients, isolated interventions may be insufficient because anatomical restriction, functional impairment, ventilatory instability, and sleep-related physiological dysfunction frequently coexist. An integrative management strategy may combine airway-directed therapies, respiratory physiotherapy, oral appliance therapy, otorhinolaryngologic interventions, and sleep-based treatments according to the patient’s clinical, physiological, and anatomical characteristics.18,19 Selection and sequencing of treatment modalities should be guided by symptom profile, craniofacial morphology, upper airway evaluation, severity of sleep-disordered breathing, hypoxic burden, and objective assessment of nocturnal oxygenation. Phenotype-oriented management has gained increasing importance in sleep medicine by emphasizing the identification of dominant contributors such as upper airway collapsibility, impaired nasal breathing, craniofacial restriction, ventilatory instability, and altered neuromuscular control.29 Tailoring interventions to these physiological and anatomical phenotypes may improve therapeutic effectiveness, treatment adherence, and long-term clinical outcomes. Longitudinal monitoring of nocturnal oxygenation, hypoxic burden, and sleep-related symptoms remains essential for dynamic treatment adjustment. Wearable nocturnal oximetry together with follow-up respiratory polygraphy or polysomnography may help identify persistent sleep-disordered breathing, residual hypoxic burden, or incomplete physiological recovery under real-life conditions. By integrating multiple disciplines and individualized therapeutic strategies, multimodal management provides a practical clinical framework for improving nocturnal ventilation, physiological oxygenation, sleep quality, and overall physiological recovery. Clinical Implications and Future Directions Recognition of nocturnal oxygenation and sleep-related airflow limitation as dynamic and potentially modifiable physiological processes has important implications for the clinical management of sleep-disordered breathing. Current diagnostic approaches remain largely centered on event-based indices such as the apnea–hypopnea index (AHI), which may not fully reflect the anatomical, functional, and physiological complexity of sleep-disordered breathing. A broader airway- and physiology-oriented perspective may improve identification of patients with clinically relevant nocturnal hypoxia despite relatively modest event frequency. Incorporating craniofacial assessment, upper airway evaluation, and objective analysis of nocturnal oxygenation into routine clinical practice may facilitate more accurate phenotypic characterization, individualized therapeutic planning, and multidisciplinary management. This approach also supports the integration of stomatological and upper airway assessment into multidisciplinary care pathways, particularly in patients with suspected anatomical restriction, chronic mouth breathing, impaired nasal airflow, or persistent sleep-related symptoms. In oncology populations, such evaluation may contribute to identifying previously unrecognized sleep-disordered breathing and chronic nocturnal hypoxia, potentially relevant to systemic physiological stress and overall patient vulnerability.30 Sleep-disordered breathing and chronic nocturnal hypoxia are multifactorial conditions. In addition to craniofacial restriction and upper airway dysfunction, factors such as obesity, aging, smoking, alcohol consumption, associated comorbidities, and cancer-related treatments may influence respiratory physiology and nocturnal oxygenation. The purpose of the present framework is not to replace these established determinants, but to emphasize that anatomical and stomatological factors may represent underrecognized contributors deserving greater attention within multidisciplinary oncology care. From a therapeutic perspective, phenotype-oriented and multimodal management strategies may improve long-term clinical outcomes by addressing both structural and functional contributors to sleep-disordered breathing. Longitudinal monitoring using wearable nocturnal oximetry together with follow-up respiratory polygraphy or polysomnography may further support individualized treatment adjustment under real-life conditions. Despite increasing interest in oxygen-centered and phenotype-oriented approaches, several important challenges remain. Standardized definitions of clinically meaningful nocturnal hypoxia, validated measures of hypoxic burden, phenotype-specific treatment algorithms, and prospective outcome-based studies are still needed. Future research should focus on validating integrative diagnostic models combining anatomical, physiological, and sleep-related parameters across diverse patient populations. Overall, this airway-centered and physiology-oriented framework proposes a complementary clinical perspective for the evaluation of sleep-disordered breathing. By integrating craniofacial anatomy, upper airway assessment, physiological characterization, and objective evaluation of nocturnal oxygenation, it may contribute to more precise phenotypic characterization, improved therapeutic personalization, and broader recognition of the systemic consequences of chronic intermittent nocturnal hypoxia. Limitations This article has several limitations that should be acknowledged. First, it represents a narrative review and a translational clinical framework rather than a systematic review. Consequently, selection bias cannot be excluded, and the studies discussed differ in design, patient populations, and methodologies used to evaluate sleep-disordered breathing, upper airway dysfunction, and nocturnal oxygenation. In addition, although increasing evidence supports the physiological relevance of chronic intermittent nocturnal hypoxia, standardized definitions of clinically meaningful nocturnal hypoxia, validated measures of hypoxic burden, and phenotype-specific therapeutic thresholds remain incompletely established. The proposed airway- and stomatology-oriented framework has not yet been prospectively validated, and its impact on clinical decision-making, therapeutic outcomes, and long-term patient prognosis remains uncertain. Furthermore, although emerging evidence suggests potential interactions between chronic intermittent nocturnal hypoxia and systemic disease processes, including cancer development and progression, direct causal relationships have not yet been conclusively established. Accordingly, the proposed framework should be regarded as a hypothesis-generating and translational clinical model whose practical utility requires confirmation through well-designed prospective clinical studies before routine implementation in clinical practice. Future prospective investigations integrating craniofacial assessment, sleep phenotyping, objective measures of hypoxic burden and nocturnal oxygenation, together with longitudinal clinical outcomes, will be essential to validate this framework and define its potential role within multidisciplinary clinical care. Conclusions Stable nocturnal breathing and physiological oxygenation are fundamental components of human health that remain incompletely recognized in the clinical evaluation and management of sleep-disordered breathing.31,32 Chronic intermittent nocturnal hypoxia, frequently associated with upper airway dysfunction and craniofacial restriction, represents a persistent and potentially modifiable source of systemic physiological stress.33,34 Current diagnostic paradigms, largely centered on event-based indices such as the apnea–hypopnea index (AHI), may not fully capture the anatomical, functional, and physiological complexity of sleep-disordered breathing. Integrating upper airway evaluation, craniofacial assessment, and objective analysis of nocturnal oxygenation provides a broader physiological framework for disease characterization, phenotypic stratification, and individualized therapeutic planning. The phenotype-oriented framework proposed in this review combines stomatological examination, upper airway assessment, sleep evaluation, and multimodal therapeutic strategies into a structured clinical approach that may improve recognition of underdiagnosed sleep-disordered breathing and chronic nocturnal hypoxia. As a translational clinical model, it is intended to support hypothesis generation and future prospective clinical investigation rather than to replace established diagnostic or therapeutic guidelines. Importantly, this airway-centered physiological perspective may have implications extending beyond sleep medicine. In oncology, systematic evaluation of upper airway anatomy, craniofacial characteristics, and nocturnal oxygenation may facilitate identification of previously unrecognized physiological vulnerability and support integration of stomatological and airway assessment into multidisciplinary clinical care. Future prospective studies are required to validate this framework, establish clinically meaningful measures of hypoxic burden, and determine whether targeted correction of anatomical and functional contributors to chronic nocturnal hypoxia can improve long-term physiological and clinical outcomes. Funding Statement No funding was received for this work. AI Use and Compliance Statement Artificial intelligence tools (ChatGPT, GPT-5.5, OpenAI, San Francisco, CA, USA) were used solely to support language editing and structural organization. All scientific content, interpretation, and conclusions were developed by the authors, who take full responsibility for the accuracy and integrity of the work. Data Sharing Statement This article is a narrative review and conceptual clinical framework and does not report new experimental or clinical datasets. The materials supporting the conclusions of this work are available from the corresponding author upon reasonable request. All published sources cited in this review are available in the peer-reviewed literature. Ethics Statement This work is a conceptual clinical overview and does not involve human participants, patient data, or animal research. Therefore, ethical approval and informed consent were not required. Author Contributions C.M.B.: Conceptualization, Methodology, Investigation, Formal analysis, Writing – Original Draft, Visualization, Project administration. C.M.G.: Investigation, Data curation, Formal analysis, Writing – Review & Editing. L.-A.B.-G.: Methodology, Validation, Supervision, Writing – Review & Editing. All authors gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work. Disclosure The authors declare no conflict of interest. References Associated Data Data Availability Statement This article is a narrative review and conceptual clinical framework and does not report new experimental or clinical datasets. The materials supporting the conclusions of this work are available from the corresponding author upon reasonable request. All published sources cited in this review are available in the peer-reviewed literature.